PR104
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PR104, covering 2011-07-07 to 2012-08-31. Get the full timeline:
Most recent: Clinical Trial Update: PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia [Phase 1, Phase 2]